Global Uterine Fibroids Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 106

Report ID: 3438

Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%–40% in women during their reproductive ages. Occasionally, these fibroids swell up and make the uterus to grow like full visible pregnancy. Mostly, there are more than one fibroid in the uterus. However, fibroids do not always cause any symptoms, their location, and size results to difficulties for few women, including pain, discomfort and heavy bleeding. Uterine fibroid can be of different types such as intramural fibroids, subserosal fibroids, pedunculated fibroids and submucosal fibroids. There can be many reasons for uterine fibroid formation but genetic problems hormonal imbalance and other factors are predominant. The cardinal symptoms of uterine fibroids are heavy menstrual bleeding, abdominal pain, excessive uterine bleeding, increased urinary frequency, anaemia and infertility. Apart from physical morbidity, uterine fibroid ailment is a frequent cause of significant damage of quality of life and a major reason for hysterectomy. Therapy has traditionally based on two extremes: medicinal management, comprising progestins, oral contraceptives and GnRH agonists and surgical management, including myomectomy, hysterectomy, and ablation for most serious cases.
Patients suffering from uterine fibroid problem represent an undeserved and huge market due to the absence of satisfactory medical treatments. Uterine fibroids affects nearly 40% of women in the age group of 30 and 55, including 20 million women in North America and 24 million women in Europe with over 7 million patients worldwide presently undergo various symptom management treatments.
In 2018, the global Uterine Fibroids market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Uterine Fibroids status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Uterine Fibroids development in United States, Europe and China.

The key players covered in this study
Boston Scientific
Cooper Surgical
C.R. Bard
F. Hoffmann-La Roche
GE Healthcare
Karl Storz Endoscopy
Richard Wolf Medical Instruments
Siemens Medical Solutions
AbbVie
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline Pharmaceuticals
Pfizer
Johnson & Johnson
Novartis

Market segment by Type, the product can be split into
Non-Hormonal Treatment
Hormonal Treatment

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Uterine Fibroids status, future forecast, growth opportunity, key market and key players.
To present the Uterine Fibroids development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Uterine Fibroids are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Uterine Fibroids Market Size Growth Rate by Type (2014-2025)
1.4.2 Non-Hormonal Treatment
1.4.3 Hormonal Treatment
1.5 Market by Application
1.5.1 Global Uterine Fibroids Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Uterine Fibroids Market Size
2.2 Uterine Fibroids Growth Trends by Regions
2.2.1 Uterine Fibroids Market Size by Regions (2014-2025)
2.2.2 Uterine Fibroids Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Uterine Fibroids Market Size by Manufacturers
3.1.1 Global Uterine Fibroids Revenue by Manufacturers (2014-2019)
3.1.2 Global Uterine Fibroids Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Uterine Fibroids Market Concentration Ratio (CR5 and HHI)
3.2 Uterine Fibroids Key Players Head office and Area Served
3.3 Key Players Uterine Fibroids Product/Solution/Service
3.4 Date of Enter into Uterine Fibroids Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Uterine Fibroids Market Size by Type (2014-2019)
4.2 Global Uterine Fibroids Market Size by Application (2014-2019)

5 United States
5.1 United States Uterine Fibroids Market Size (2014-2019)
5.2 Uterine Fibroids Key Players in United States
5.3 United States Uterine Fibroids Market Size by Type
5.4 United States Uterine Fibroids Market Size by Application

6 Europe
6.1 Europe Uterine Fibroids Market Size (2014-2019)
6.2 Uterine Fibroids Key Players in Europe
6.3 Europe Uterine Fibroids Market Size by Type
6.4 Europe Uterine Fibroids Market Size by Application

7 China
7.1 China Uterine Fibroids Market Size (2014-2019)
7.2 Uterine Fibroids Key Players in China
7.3 China Uterine Fibroids Market Size by Type
7.4 China Uterine Fibroids Market Size by Application

8 Japan
8.1 Japan Uterine Fibroids Market Size (2014-2019)
8.2 Uterine Fibroids Key Players in Japan
8.3 Japan Uterine Fibroids Market Size by Type
8.4 Japan Uterine Fibroids Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Uterine Fibroids Market Size (2014-2019)
9.2 Uterine Fibroids Key Players in Southeast Asia
9.3 Southeast Asia Uterine Fibroids Market Size by Type
9.4 Southeast Asia Uterine Fibroids Market Size by Application

10 India
10.1 India Uterine Fibroids Market Size (2014-2019)
10.2 Uterine Fibroids Key Players in India
10.3 India Uterine Fibroids Market Size by Type
10.4 India Uterine Fibroids Market Size by Application

11 Central & South America
11.1 Central & South America Uterine Fibroids Market Size (2014-2019)
11.2 Uterine Fibroids Key Players in Central & South America
11.3 Central & South America Uterine Fibroids Market Size by Type
11.4 Central & South America Uterine Fibroids Market Size by Application

12 International Players Profiles
12.1 Boston Scientific
12.1.1 Boston Scientific Company Details
12.1.2 Company Description and Business Overview
12.1.3 Uterine Fibroids Introduction
12.1.4 Boston Scientific Revenue in Uterine Fibroids Business (2014-2019)
12.1.5 Boston Scientific Recent Development
12.2 Cooper Surgical
12.2.1 Cooper Surgical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Uterine Fibroids Introduction
12.2.4 Cooper Surgical Revenue in Uterine Fibroids Business (2014-2019)
12.2.5 Cooper Surgical Recent Development
12.3 C.R. Bard
12.3.1 C.R. Bard Company Details
12.3.2 Company Description and Business Overview
12.3.3 Uterine Fibroids Introduction
12.3.4 C.R. Bard Revenue in Uterine Fibroids Business (2014-2019)
12.3.5 C.R. Bard Recent Development
12.4 F. Hoffmann-La Roche
12.4.1 F. Hoffmann-La Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Uterine Fibroids Introduction
12.4.4 F. Hoffmann-La Roche Revenue in Uterine Fibroids Business (2014-2019)
12.4.5 F. Hoffmann-La Roche Recent Development
12.5 GE Healthcare
12.5.1 GE Healthcare Company Details
12.5.2 Company Description and Business Overview
12.5.3 Uterine Fibroids Introduction
12.5.4 GE Healthcare Revenue in Uterine Fibroids Business (2014-2019)
12.5.5 GE Healthcare Recent Development
12.6 Karl Storz Endoscopy
12.6.1 Karl Storz Endoscopy Company Details
12.6.2 Company Description and Business Overview
12.6.3 Uterine Fibroids Introduction
12.6.4 Karl Storz Endoscopy Revenue in Uterine Fibroids Business (2014-2019)
12.6.5 Karl Storz Endoscopy Recent Development
12.7 Richard Wolf Medical Instruments
12.7.1 Richard Wolf Medical Instruments Company Details
12.7.2 Company Description and Business Overview
12.7.3 Uterine Fibroids Introduction
12.7.4 Richard Wolf Medical Instruments Revenue in Uterine Fibroids Business (2014-2019)
12.7.5 Richard Wolf Medical Instruments Recent Development
12.8 Siemens Medical Solutions
12.8.1 Siemens Medical Solutions Company Details
12.8.2 Company Description and Business Overview
12.8.3 Uterine Fibroids Introduction
12.8.4 Siemens Medical Solutions Revenue in Uterine Fibroids Business (2014-2019)
12.8.5 Siemens Medical Solutions Recent Development
12.9 AbbVie
12.9.1 AbbVie Company Details
12.9.2 Company Description and Business Overview
12.9.3 Uterine Fibroids Introduction
12.9.4 AbbVie Revenue in Uterine Fibroids Business (2014-2019)
12.9.5 AbbVie Recent Development
12.10 AstraZeneca
12.10.1 AstraZeneca Company Details
12.10.2 Company Description and Business Overview
12.10.3 Uterine Fibroids Introduction
12.10.4 AstraZeneca Revenue in Uterine Fibroids Business (2014-2019)
12.10.5 AstraZeneca Recent Development
12.11 Bayer
12.12 Eli Lilly
12.13 GlaxoSmithKline Pharmaceuticals
12.14 Pfizer
12.15 Johnson & Johnson
12.16 Novartis

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details